13
Views
13
CrossRef citations to date
0
Altmetric
Special Report

Blood pressure-lowering drugs: essential therapy for some patients with normal blood pressure

Pages 771-775 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Flávio Danni Fuchs. (2009) Diuretics: still essential drugs for the management of hypertension. Expert Review of Cardiovascular Therapy 7:6, pages 591-598.
Read now
Flávio D Fuchs, Patrícia Guerrero & Miguel Gus. (2007) What is next when the first blood pressure-lowering drug is not sufficient?. Expert Review of Cardiovascular Therapy 5:3, pages 435-439.
Read now

Articles from other publishers (11)

Eveline M. Bezerra, Érika C. de Alvarenga, Ricardo P. dos Santos, Jeanlex S. de Sousa, Umberto L. Fulco, Valder N. Freire, Eudenilson L. Albuquerque & Roner F. da Costa. (2022) Losartan as an ACE inhibitor: a description of the mechanism of action through quantum biochemistry. RSC Advances 12:44, pages 28395-28404.
Crossref
Flávio Danni Fuchs & Sandra Costa Fuchs. 2019. Prehypertension and Cardiometabolic Syndrome. Prehypertension and Cardiometabolic Syndrome 643 656 .
Flávio D. Fuchs, Sandra C. Fuchs, Carlos E. Poli-de-Figueiredo, José A. Figueiredo Neto, Luiz César N. Scala, José F. Vilela-Martin, Leila B. Moreira, Hilton Chaves, Marco Mota Gomes, Marcos R. de Sousa, Ricardo Pereira e Silva, Iran Castro, Evandro José Cesarino, Ana Luiza Lima Sousa, João Guilherme Alves, André Avelino Steffens, Andréa Araujo Brandão, Luiz Aparecido Bortolotto, Abrahão Afiune Neto, Antônio C. Nóbrega, Roberto Silva Franco, Dario C. Sobral Filho, Fernando Nobre, Rosane Schlatter, Miguel Gus, Caroline Nespolo De David, Leticia Rafaelli, Guilhermo Prates Sesin, Otávio Berwanger & Paul K. Whelton. (2018) Effectiveness of low-dose diuretics for blood pressure reduction to optimal values in prehypertension. Journal of Hypertension 36:4, pages 933-938.
Crossref
Flávio Danni FuchsFlávio Danni Fuchs. 2018. Essentials of Hypertension. Essentials of Hypertension 101 145 .
Flávio Danni FuchsFlávio Danni Fuchs. 2018. Essentials of Hypertension. Essentials of Hypertension 1 38 .
Flávio Danni Fuchs, Renato Bandeira de Mello & Sandra Costa Fuchs. (2014) Preventing the Progression of Prehypertension to Hypertension: Role of Antihypertensives. Current Hypertension Reports 17:1.
Crossref
F D Fuchs & S C Fuchs. (2013) Blood pressure targets in the treatment of high blood pressure: a reappraisal of the J-shaped phenomenon. Journal of Human Hypertension 28:2, pages 80-84.
Crossref
Flávio D Fuchs, Sandra C Fuchs, Leila B Moreira, Miguel Gus, Antônio C Nóbrega, Carlos E Poli-de-Figueiredo, Décio Mion, Luiz Bortoloto, Fernanda Consolim-Colombo, Fernando Nobre, Eduardo Barbosa Coelho, José F Vilela-Martin, Heitor MorenoJrJr, Evandro José Cesarino, Roberto Franco, Andréa Araujo Brandão, Marcos R de Sousa, Antônio Luiz Pinho Ribeiro, Paulo Cesar Jardim, Abrahão Afiune Neto, Luiz César N Scala, Marco Mota, Hilton Chaves, João Guilherme Alves, Dario C Sobral Filho, Ricardo Pereira e Silva, José A Figueiredo Neto, Maria Cláudia Irigoyen, Iran Castro, André Avelino Steffens, Rosane Schlatter, Renato Bandeira de Mello, Francisca Mosele, Flávia Ghizzoni & Otávio Berwanger. (2011) Prevention of hypertension in patients with pre-hypertension: protocol for the PREVER-prevention trial. Trials 12:1.
Crossref
Flávio Danni Fuchs. (2010) Prehypertension: the Rationale for Early Drug Therapy. Cardiovascular Therapeutics 28:6, pages 339-343.
Crossref
Hisashi IIJIMA, Tomoka OSUMI & Toshimasa KOSHIMIZU. (2010) Development and Analyses of Evaluation Criteria for Meta-analysis-Relationship between Renin-Angiotensin System Inhibitor and Diabetes Mellitus-メタアナリシス論文における評価基準の作成と分析 ~糖尿病とレニン・アンジオテンシン系阻害薬の関連~. YAKUGAKU ZASSHI 130:9, pages 1215-1223.
Crossref
Hisao MORI, Hiroshi UKAI, Hareaki YAMAMOTO, Saburo SAITOU, Kouich HIRAO, Mikio YAMAUCHI & Satoshi UMEMURA. (2006) Current Status of Antihypertensive Prescription and Associated Blood Pressure Control in Japan. Hypertension Research 29:3, pages 143-151.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.